Platelet transfusions and mortality in necrotizing enterocolitis.
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
25
01
2018
revised:
07
11
2018
accepted:
08
11
2018
pubmed:
1
1
2019
medline:
9
11
2019
entrez:
1
1
2019
Statut:
ppublish
Résumé
Prior studies have suggested an association between platelet transfusions (PTXs) and worse outcomes among infants with necrotizing enterocolitis (NEC), potentially mediated by proinflammatory factors released by platelets. However, the effects of storage on platelet proinflammatory factor release and the confounding role of illness severity on NEC outcomes have not been determined. First, neuropeptide Y (a potent splanchnic vasoconstrictor released by platelets) was measured by enzyme-linked immunosorbent assay in fresh frozen plasma and in the supernatant of leukoreduced apheresis-derived platelets at different times during storage. Next, we evaluated the relationship between PTX rates and death in a multicenter cohort of very-low-birth-weight infants with NEC, adjusting for illness severity. Neuropeptide Y levels increased over time in the supernatant of leukoreduced apheresis-derived platelets and were 4.4-fold and 8.9-fold higher than in fresh frozen plasma on Days 2 and 3 of storage, respectively (p < 0.001). Among 598 very-low-birth-weight infants, 44 developed NEC. In unadjusted analysis, PTX rate was 30.3 (95% confidence interval [CI], 11.5-80.1) per 100 infant-days among infants who died, compared to 6.0 (95% CI, 3.2-11.2) among survivors (incidence rate ratio, 5.1; 95% CI, 1.6-16.2; p = 0.006). In multivariable analysis, there was no association between PTX rate and mortality (incidence rate ratio, 3.0; 95% CI, 0.6-15.0; p = 0.18), although estimation was imprecise. Proinflammatory mediators accumulate in platelet suspensions during storage. Although PTX rates were not associated with increased mortality among infants with NEC in our study, our estimates suggest the potential for such an association that needs evaluation in larger studies.
Sections du résumé
BACKGROUND
Prior studies have suggested an association between platelet transfusions (PTXs) and worse outcomes among infants with necrotizing enterocolitis (NEC), potentially mediated by proinflammatory factors released by platelets. However, the effects of storage on platelet proinflammatory factor release and the confounding role of illness severity on NEC outcomes have not been determined.
STUDY DESIGN AND METHODS
First, neuropeptide Y (a potent splanchnic vasoconstrictor released by platelets) was measured by enzyme-linked immunosorbent assay in fresh frozen plasma and in the supernatant of leukoreduced apheresis-derived platelets at different times during storage. Next, we evaluated the relationship between PTX rates and death in a multicenter cohort of very-low-birth-weight infants with NEC, adjusting for illness severity.
RESULTS
Neuropeptide Y levels increased over time in the supernatant of leukoreduced apheresis-derived platelets and were 4.4-fold and 8.9-fold higher than in fresh frozen plasma on Days 2 and 3 of storage, respectively (p < 0.001). Among 598 very-low-birth-weight infants, 44 developed NEC. In unadjusted analysis, PTX rate was 30.3 (95% confidence interval [CI], 11.5-80.1) per 100 infant-days among infants who died, compared to 6.0 (95% CI, 3.2-11.2) among survivors (incidence rate ratio, 5.1; 95% CI, 1.6-16.2; p = 0.006). In multivariable analysis, there was no association between PTX rate and mortality (incidence rate ratio, 3.0; 95% CI, 0.6-15.0; p = 0.18), although estimation was imprecise.
CONCLUSION
Proinflammatory mediators accumulate in platelet suspensions during storage. Although PTX rates were not associated with increased mortality among infants with NEC in our study, our estimates suggest the potential for such an association that needs evaluation in larger studies.
Identifiants
pubmed: 30597571
doi: 10.1111/trf.15112
pmc: PMC6402966
mid: NIHMS1004664
doi:
Substances chimiques
Neuropeptide Y
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
981-988Subventions
Organisme : NHLBI NIH HHS
ID : P01 HL046925
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133022
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL124078
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL069990
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL128942
Pays : United States
Informations de copyright
© 2018 AABB.
Références
J Perinatol. 2005 Mar;25(3):173-7
pubmed: 15578029
N Engl J Med. 2011 Jan 20;364(3):255-64
pubmed: 21247316
Semin Perinatol. 2008 Apr;32(2):100-6
pubmed: 18346533
Sci Rep. 2018 Feb 15;8(1):3101
pubmed: 29449599
Vox Sang. 2002 Aug;83(2):125-36
pubmed: 12201842
J Pediatr. 2001 Jan;138(1):92-100
pubmed: 11148519
JAMA Pediatr. 2014 Nov;168(11):1054-62
pubmed: 25243446
Lipids. 1991 Dec;26(12):1340-3
pubmed: 1819729
Zhongguo Yao Li Xue Bao. 1995 Jul;16(4):360-5
pubmed: 7668111
Blood. 2006 Oct 1;108(7):2455-62
pubmed: 16772606
Transfusion. 2011 Dec;51(12):2634-41
pubmed: 21658049
Pediatr Surg Int. 2009 Apr;25(4):309-18
pubmed: 19301015
Transfusion. 1996 May;36(5):445-9
pubmed: 8693510
Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):590-600
pubmed: 27534694
Transfus Med. 2012 Oct;22(5):338-43
pubmed: 22738179
Nature. 1982 Apr 15;296(5858):659-60
pubmed: 6896083
Pediatrics. 2009 Dec;124(6):e1095-100
pubmed: 19917581
Pediatrics. 2009 Jan;123(1):278-85
pubmed: 19117893
Pediatrics. 2009 Nov;124(5):e826-34
pubmed: 19841111
Transfus Med. 2001 Dec;11(6):403-17
pubmed: 11851938
N Engl J Med. 1994 Sep 8;331(10):625-8
pubmed: 8052271
Transfus Med Rev. 2011 Apr;25(2):125-32
pubmed: 21345642
Regul Pept. 2002 Nov 15;109(1-3):189-92
pubmed: 12409232
Peptides. 2002 Feb;23(2):349-58
pubmed: 11825649
Inflamm Res. 2000 Sep;49(9):466-72
pubmed: 11071121
Transfusion. 2009 May;49(5):869-72
pubmed: 19175546
Neuropeptides. 2016 Feb;55:127-35
pubmed: 26431933
Lancet. 1987 May 9;1(8541):1057-9
pubmed: 2883396
Regul Pept. 1993 Sep 22;47(3):239-45
pubmed: 8234908
Transfusion. 1999 May;39(5):498-505
pubmed: 10336000
Blood Transfus. 2018 Jan;16(1):63-72
pubmed: 27643752
JAMA. 2016 Mar 1;315(9):889-97
pubmed: 26934258
Blood Transfus. 2017 Mar;15(2):145-152
pubmed: 28263172
N Engl J Med. 2019 Jan 17;380(3):242-251
pubmed: 30387697
Transfusion. 2000 Jul;40(7):781-8
pubmed: 10924604
JAMA Pediatr. 2017 Mar 6;171(3):e164396
pubmed: 28068438
Shock. 2006 Apr;25(4):329-37
pubmed: 16670633
FASEB J. 2013 Jun;27(6):2244-55
pubmed: 23457218
Expert Rev Mol Med. 2016 Jun 24;18:e12
pubmed: 27341512
Hematology. 1997;2(6):473-84
pubmed: 27415844